Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Moderna (MRNA) is a tokenized stock pegged 1:1 to the value of the Moderna stock on a regulated exchange. Please note that when you buy a tokenised stock, you have no ownership in the company, you can only benefit from the economic performance of the stock.
- Market cap
- 52-week high
- 52-week low